Proteomics International Laboratories Ltd (ASX:PIQ)
Australia · Delayed Price · Currency is AUD 0.3350
-0.0050 (-1.47%)
Mar 11, 2026, 4:10 PM AEST
ASX:PIQ Market Cap
ASX:PIQ has a market cap or net worth of 55.34 million as of March 11, 2026. Its market cap has decreased by -30.18% in one year.
Market Cap
55.34M
Enterprise Value
47.88M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
Market Cap Chart
Since April 16, 2015, ASX:PIQ's market cap has increased from 11.39M to 55.34M, an increase of 386.05%. That is a compound annual growth rate of 15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 56.16M | -47.64% |
| Dec 31, 2025 | 107.27M | 2.36% |
| Dec 31, 2024 | 104.80M | -4.28% |
| Dec 29, 2023 | 109.49M | -0.29% |
| Dec 30, 2022 | 109.81M | -14.46% |
| Dec 31, 2021 | 128.37M | 53.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 81.80M |
| Cynata Therapeutics | 80.73M |
| Alterity Therapeutics | 76.13M |
| Radiopharm Theranostics | 74.43M |
| Imugene | 73.95M |
| Prescient Therapeutics | 57.83M |
| Neurizon Therapeutics | 57.29M |
| Amplia Therapeutics | 56.44M |